Voyager Therapeutics (VYGR) Revenue (2015 - 2026)
Voyager Therapeutics (VYGR) reported Revenue of $2.6 million for Q1 2026, down 59.94% on a YoY basis from $6.5 million in Q1 2025, and down 83.13% sequentially from $15.4 million in Q4 2025.
Voyager Therapeutics (VYGR) Revenue (2015 - 2026) Analysis & Trends
Voyager Therapeutics (VYGR) has 12 years of Revenue data on file, last reported at $2.6 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue fell 59.94% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $36.5 million (down 45.46% YoY), and the FY2025 full-year result was $40.4 million, down 49.53% from the prior year.
- Revenue retreated to $2.6 million in Q1 2026, from $15.4 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $150.5 million in Q1 2023 to a low of -$1.5 million in Q4 2022.
- A 5-year average of $24.4 million and a median of $6.5 million in 2025 frame the typical range for Revenue.
- Across the five-year window, Revenue slumped 105.52% in 2022 and jumped 22769.3% in 2023, its largest moves.
- Tracing VYGR's Revenue over 5 years: stood at -$1.5 million in 2022, then surged by 5913.42% to $90.1 million in 2023, then tumbled by 93.01% to $6.3 million in 2024, then surged by 143.99% to $15.4 million in 2025, then slumped by 83.13% to $2.6 million in 2026.
- Business Quant data shows VYGR's Revenue at $2.6 million in Q1 2026, $15.4 million in Q4 2025, and $13.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 15.37 Mn |
| Sep 30, 2025 | 13.37 Mn |
| Jun 30, 2025 | 5.20 Mn |
| Mar 31, 2025 | 6.47 Mn |
| Dec 31, 2024 | 6.30 Mn |
| Sep 30, 2024 | 24.63 Mn |
| Jun 30, 2024 | 29.58 Mn |
| Mar 31, 2024 | 19.50 Mn |
| Dec 31, 2023 | 90.11 Mn |
| Sep 30, 2023 | 4.61 Mn |
| Jun 30, 2023 | 4.90 Mn |
| Mar 31, 2023 | 150.48 Mn |
| Dec 31, 2022 | -1.55 Mn |
| Sep 30, 2022 | 41.09 Mn |
| Jun 30, 2022 | 712,000.00 |
| Mar 31, 2022 | 658,000.00 |
| Dec 31, 2021 | 28.07 Mn |
| Sep 30, 2021 | 1.48 Mn |
| Jun 30, 2021 | 1.36 Mn |